Saturday, August 29, 2015 11:58:58 PM
Unfortunately some incorrect information persists that "no side effects" means "no therapeutic effect" of a drug
From Drugs.com, the definition of side effect is usually regarded as "...an undesirable secondary effect in addition to the desired therapeutic effect of a drug or medication". In Sucanon studies, primary study variables were associated with blood sugar control, both short and long term. A secondary effect of decreased visceral body fat was also observed. Is this considered a side effect? Perhaps because it is a secondary effect to the primary study variable of blood sugar control. I suspect most with diabetes or in danger of developing it would not consider loss of visceral body fat an undesirable effect, though. In addition, the typical undesired effects common with many other diabetes drugs, weight gain, fluid retention etc were not observed in Sucanon studies. Therefore, while "no side effects" may be an oversimplification and it may be technically more accurate to say no negative secondary effects were observed with Sucanon use, as the positive effect of decreased visceral body fat is reported. In any case I don't see a conflict with the above side effect definition.
It is likely that both blood sugar and body fat effects are important in those at risk for diabetes or in early stages, especially considering many of the significant and undesirable secondary effects of many other oral diabetes medications.
Anyhow, I hope this helps clear up some of the apparent confusion on "side effects" and Sucanon
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM